In Vitro Susceptibility of Citrobacter Species to Various Antimicrobial Agents

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1987 May 1

PMID 3606084

Citations 10

Authors

G Samonis

D H Ho

G F Gooch

K V Rolston

G P Bodey

Affiliations

Soon will be listed here.

Abstract

The in vitro activities of 16 antimicrobial agents against 14 clinical isolates of Citrobacter diversus and 27 isolates of Citrobacter freundii were studied. C. freundii isolates were more resistant, being susceptible only to amikacin, netilmicin, gentamicin, imipenem, ciprofloxacin, and enoxacin. C. diversus isolates were susceptible to many more of the agents tested.

Citing Articles

Comparative Genomic Analysis of and Key Genes Essential for the Pathogenicity of .

Yuan C, Yin Z, Wang J, Qian C, Wei Y, Zhang S Front Microbiol. 2019; 10:2774.

PMID: 31866966 PMC: 6908497. DOI: 10.3389/fmicb.2019.02774.

Community-Acquired Pneumonia and Empyema Caused by Citrobacter koseri in an Immunocompetent Patient.

Ariza-Prota M, Pando-Sandoval A, Garcia-Clemente M, Fernandez R, Casan P Case Rep Pulmonol. 2015; 2015:670373.

PMID: 26634165 PMC: 4655040. DOI: 10.1155/2015/670373.

Complete Genome Sequence of Citrobacter freundii Myophage Moon.

Edwards G, Luna A, Hernandez A, Kuty Everett G Genome Announc. 2015; 3(1).

PMID: 25635027 PMC: 4319498. DOI: 10.1128/genomeA.01427-14.

Multidrug resistant citrobacter: an unusual cause of liver abscess.

Kumar P, Ghosh S, Rath D, Gadpayle A BMJ Case Rep. 2013; 2013.

PMID: 23608848 PMC: 3645642. DOI: 10.1136/bcr-2013-008714.

Citrobacter brain abscesses in neonates: early surgical intervention and review of the literature.

Chowdhry S, Cohen A Childs Nerv Syst. 2012; 28(10):1715-22.

PMID: 22526440 DOI: 10.1007/s00381-012-1746-4.

References

Bodey G, Buckley M, SATHE Y, Freireich E . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64(2):328-40. DOI: 10.7326/0003-4819-64-2-328. View

Hodges G, Degener C, Barnes W . Clinical significance of citrobacter isolates. Am J Clin Pathol. 1978; 70(1):37-40. DOI: 10.1093/ajcp/70.1.37. View

Fainstein V, Weaver S, Bodey G . Comparative in vitro study of SQ26,776. Antimicrob Agents Chemother. 1982; 21(2):294-8. PMC: 181876. DOI: 10.1128/AAC.21.2.294. View

Lipsky B, Hook 3rd E, Smith A, PLORDE J . Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis. 1980; 2(5):746-60. DOI: 10.1093/clinids/2.5.746. View

Garcia I, Bodey G, Fainstein V, Ho D, LeBlanc B . In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients. Antimicrob Agents Chemother. 1984; 26(3):421-3. PMC: 176185. DOI: 10.1128/AAC.26.3.421. View

Toda M, Arao N, Nohara C, Susaki K, Tachibana A . In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985; 27(4):565-9. PMC: 180096. DOI: 10.1128/AAC.27.4.565. View

Hoy J, Rolston K, Ho D, Alvarez M, Thirolf P, Bodey G . In vitro activity of BRL 36650, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1986; 29(6):972-6. PMC: 180486. DOI: 10.1128/AAC.29.6.972. View

Fuchs P, Jones R, Barry A, Thornsberry C . Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985; 27(5):679-82. PMC: 180130. DOI: 10.1128/AAC.27.5.679. View

Drelichman V, Band J . Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med. 1985; 145(10):1808-10. View

10.

Eliopoulos G, Moellering A, Reiszner E, Moellering Jr R . In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrob Agents Chemother. 1985; 28(4):514-20. PMC: 180295. DOI: 10.1128/AAC.28.4.514. View

11.

Henry D, Skidmore A, Smith A, Smith J . In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Antimicrob Agents Chemother. 1985; 28(2):259-64. PMC: 180229. DOI: 10.1128/AAC.28.2.259. View

12.

Benson C, WALTON F, Trenholme G . Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli. Antimicrob Agents Chemother. 1986; 29(1):155-7. PMC: 180383. DOI: 10.1128/AAC.29.1.155. View

13.

MANDELL W, Neu H . In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents. Antimicrob Agents Chemother. 1986; 29(5):852-7. PMC: 284166. DOI: 10.1128/AAC.29.5.852. View

14.

Vuye A, Pijck J . In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin. Antimicrob Agents Chemother. 1985; 27(4):574-7. PMC: 180098. DOI: 10.1128/AAC.27.4.574. View